/userfiles/images/zakladki/polpharma_z.jpg)
Polpharma’s manufacturing activity is carried out in Starogard Gdański, in GMP-compliant facilities.
Polpharma is the largest manufacturer of drugs and active pharmaceutical ingredients (APIs) in Poland. Our extensive portfolio creates possibilities for competing in various areas of the market. Polpharma's products are exported to over 50 countries of the world.
|
Finished dosage forms |
more |
|
Fine chemicals |
more |
|
In-licensing |
more |
|
Out-licensing |
more |
/userfiles/images/zakladki/api_z.jpg)
/userfiles/images/zakladki/media_z.jpg)
We respect the needs of our employees, business partners, local communities and social organizations. In every aspect of our activity we observe the highest standards of due diligence and professionalism.
We take care to ensure that the information about the Company’s activities and achievements presented by us is reliable. In this section we provide you with, among other things, our publications, film materials, and other information useful for journalists.
Browse following materials:
|
Corporate brochure |
more |
|
Environmental sustainability reports |
more |
|
Awards and distinctions for company |
more |
|
Awards and distinctions for products |
more |
Quick links
Polpharma’s annual production: approx. 200 m containers with drugs that, arranged one after the other, would occupy one-third of the equator. The area of Polpharma’s solid form manufacturing facility is 25,000 sq m,...
Good Manufacturing Practice (GMP) is an EU and worldwide standard that was developed by the Food and Drug Administration (FDA), which is a United States agency that is responsible for approving medicines and foodstuffs...
About Us |
Polpharma is a leading player in generic market in Poland. For over 70 years it has been trusted by patients, physicians, pharmacists and business partners.
Strengths |
We Help People of Science |
In 2001, Polpharma established the Foundation for Development of Polish Pharmacy and Medicine. Its mission is to support the development of pharmaceutical and medical sciences.